Tag: IDE study
Spineart secures CHF20 million funding following completed enrolment in IDE trials
Spineart has announced that it has successfully raised CHF20 million in convertible financing—an announcement that follows the completion of enrolment in the company’s two BAGUERA C...
Orthofix announces first patient implant in the M6-C artificial cervical disc...
Orthofix has announced the first patient implant in a US Food and Drug Administration (FDA) investigational device exemption (IDE) study that will evaluate the...